Today's reality and the hopes of tomorrow of the COVID-19 pandemic—an updated mapping of vaccines authorized by regulatory bodies and those close to it.
A win-win-win for sites, sponsors, and referral partners.
Approaches sponsors, CROs, and investigators can take from the DMD experience.
Balancing these tools with operational efficiencies can aid CROs in meeting the evolving needs of sponsors.
As market factors drive the rapid growth of decentralized clinical trials, organizations should embrace risk-based quality management to evaluate the new dimensions of risk and ensure effective oversight of disparate data sources, writes John Hall.
While televisits can address many medical concerns, one frequent reservation expressed by healthcare professionals is that patients during these televisits tend to present too narrow a picture of their clinical condition-resulting in non-comprehensive medical assessments.
Sites not expected to fade away even as DCTs continue to grow past COVID-19.
Clinical research sites feel growing pressure to perform work in a compliant manner while keeping pace with stakeholder information exchange workstreams, but lack the consistent processes to do so.
Spearheaded by disease foundations, the creation of clinical registries is streamlining data collection and driving informed decisions.
Biometric functional services, more than any other, can have a significant impact through the standardization of data collection and management.
Survey uncovers pediatric-patient perspectives on plain language summaries.
Robust data sets which can effectively represent diverse populations are key to driving greater inclusivity in trials.
Examining those technology-supported areas that sponsors, CROs, and sites consider the most valuable.
In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.
The potential of PBPK modeling in answering key questions around these drugs.
The emergence of AI-powered simulants in improving study efficiency.
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
A focus on data and process excellence advances product development.
The fear of exposure to SARS-CoV-2 in healthcare settings has deterred people from seeking care for non-COVID-19 diseases. One solution to patient care and biomedical research disruptions is implementing remote solutions for conducting research and collecting samples.
Examining the behaviors of clinical trial stakeholders to better understand challenges in patient participation.
Keys to ensuring your clinical trials better reflect your target population.
Data is the heart of clinical trials, so life sciences firms need to integrate their technology to keep data sources and trial portfolios up-to-date and secure.
Webinar Date/Time: Wed, Sep 20, 2023 10:00 AM EDT
Overcoming saturation in the cell therapy landscape.
With an increasing amount of diverse data that must now be collected and analyzed, the industry is faced with increasingly complex studies that present new challenges in data management.
Lessons from six months of conducting clinical trials during the COVID-19 pandemic
Learn how your team can use EHR-to-EDC technology to reduce data monitoring costs, speed up data cleaning timelines, and hit study milestones faster.
A pharmaceutical company aimed to launch a Phase III clinical trial for a new oncology drug, focusing on efficient and effective patient recruitment across diverse regions. They evaluated patient populations by analyzing demographics, social determinants of health, and geography. Investigator profiling included practice details, affiliations, referral networks, and clinical trial experience. The final step involved selecting and extracting target lists for implementation.
Anticipating the need for both virtual and traditional sites during the planning process can provide high ROI for sponsors.